Is Interpace Biosciences Inc stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Interpace Biosciences Inc 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $5.90, you would have made a loss of $-3.22 per share or -54.57%
No, the average daily trading liquidity for Interpace Biosciences Inc is $11 530 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Interpace Biosciences Inc has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 3.87, the company's ability to pay off the debt is good. Interpace Biosciences Inc has a good net profit margin of 10.47% and should have high tolerances against inflation.
We have calculated the inflation risk for Interpace Biosciences Inc to be low [0.1 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.